In younger early-onset Alzheimer’s disease patients, rapid hypermethylation on TRIM59 resulted in a lower age prediction accuracy, with an MAE of 12.2 years, as opposed to 5.7 years for healthy controls. Here, TRIM59 is linked to Alzheimer disease.